Caterol

Quick links to important sections

Caterol

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Caterol

Property Description
Active ingredient Procaterol hydrochloride hydrate
Form Oral (Syrup, Tablets), Inhalation (Nebulized solution, DPI)
Pharmacological class Selective Beta-2-Adrenoreceptor Agonist
Common use Relief of breathing difficulty / Airway widening
Origin Synthetic organic quinoline derivative

Caterol is a prominent trade name for the medicine containing the active ingredient Procaterol, which is officially classified as a Selective Beta-2-Adrenoreceptor Agonist, placing it within the pharmacological group of bronchodilators. Procaterol itself is a synthetic organic quinoline derivative. This classification signifies its unique mechanism: it is designed to specifically target the beta-2 receptors primarily located on the smooth muscles of the airways. The utility of this high selectivity is clinically recognized for minimizing systemic side effects while maximizing local bronchodilatory action.

Composition and Available Forms of Caterol

The therapeutic compound in this medicine is Procaterol hydrochloride hydrate, which functions as the single-ingredient product. Procaterol is offered in forms optimized for both systemic and local delivery, including both oral preparations (syrup and tablets) and various targeted inhalation products, such as nebulized solutions. The availability of a palatable syrup formulation, for instance, allows for easier administration to pediatric patient groups, distinguishing it from products primarily offered only in inhalation form. The distinct formulations are essential for aligning the route of administration with the desired speed and duration of action.

What is the General Purpose of This Type of Medicine?

The general purpose of a selective beta-2 agonist like Procaterol is to provide targeted relief from the physical restriction of the airways. By engaging the beta-2 receptors, the medicine triggers airway muscle relaxation, a physiological action that directly counteracts the involuntary narrowing of the bronchial tubes. This mechanism achieves targeted bronchodilation, resulting in the essential benefit of increased airflow in the lungs. This type of medicine is typically used to help reduce the sensation of chest tightness and ease the physical difficulty associated with compromised respiration.

What side effects are possible with Caterol?

Possible side effects and safety information

The officially documented safety profile of Procaterol (Caterol), a selective beta-2-adrenoreceptor agonist, primarily outlines systemic effects consistent with this pharmacological class, as detailed in regulatory documents.

Frequency and Organ Systems Affected

Adverse reactions are classified based on reported frequency in clinical data. Effects are often observed in the following System-Organ Classes:

  • Cardiac Disorders: Including palpitations, tachycardia, and changes to heart rhythm.
  • Nervous System Disorders: Common reactions documented are tremor, headache, and insomnia.
  • Gastrointestinal Disorders: Nausea and vomiting are also listed among the common adverse reactions.
  • Hepatobiliary Disorders: Official reports note elevations in liver enzymes (transaminases).

Clinically Significant and Serious Adverse Reactions

Regulatory documentation highlights specific low-incidence, serious adverse reactions that warrant attention:

  • Serious Hypokalemia: A significant decrease in serum potassium levels, which carries the risk of aggravating cardiac arrhythmias, especially in susceptible individuals.
  • Anaphylactic Reactions: Including severe hypersensitivity symptoms such as shock, which are explicitly mentioned as serious events in official labeling.

Constraints and Safety Patterns

The safety profile includes restrictions and patterns related to use:

  • Time-Related Pattern: Certain systemic effects, such as tremor or nervousness, may be more pronounced at the beginning of treatment or during any dose escalation.
  • Safety Constraints: Official cautions are mandated for patient groups with pre-existing conditions, including Hyperthyroidism, Severe Heart Disease (e.g., coronary insufficiency), and Diabetes Mellitus, due to the potential for exacerbation of these conditions.
  • Concomitant Use: Increased risk of severe adverse reactions, specifically cardiac arrhythmias and hypokalemia, is noted when used concurrently with certain medications, such as other sympathomimetic agents or diuretics.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information for Caterol

Feature Official Regulatory Statements
Documented overdose presentations Overdosage with Procaterol has been associated with cardiovascular and neurological manifestations, including tachycardia, tachycardiac arrhythmia, hypotension, tremor, and nervousness.
Physiological systems affected (as stated in label) Metabolic abnormalities documented include hypokalemia, hyperglycemia, and lactic acidosis.
Dose-related or exposure-related factors Severe and potentially life-threatening outcomes, such as cardiac arrhythmia and cardiac arrest, are linked to the continuous administration of excessive amounts of the drug.
Population-specific overdose notes No specific population-based overdose considerations are explicitly documented in the official overdose sections reviewed.
Emergency-response statements The medication should be discontinued immediately. If required, gastric lavage should be performed to remove unabsorbed drug, and emergency treatment and general maintenance therapy must be provided.
When immediate medical help is required Upon the observation of any overdosage-related abnormalities, the patient must be instructed to consult a physician as soon as possible to receive adequate medical management.

Overdose classifications (high-level)

Classification Official Regulatory Wording (as defined in documents)
Severity classification (as defined in official documents) The overdose is classified as potentially life-threatening due to the documented risk of cardiac arrest resulting from excessive use.
Regulatory basis (EMA / FDA / etc.) Prescribing Information / Product Insert (U.S. and equivalent international regulatory documents).
Overdose-context constraints Specific monitoring for hypokalemia and hyperglycemia is required, as the drop in serum potassium may potentiate cardiac arrhythmias.

Resulting overdose structure

Official overdose statements:

  • Overdosage is associated with tachycardia, tremor, and hypotension, alongside metabolic changes like hypokalemia and hyperglycemia.
  • Cardiac arrhythmia and cardiac arrest are documented risks linked to continuous administration of excessive amounts.
  • The drug should be discontinued immediately, and the patient must consult a physician as soon as possible for any observed abnormalities.
  • Management includes performing gastric lavage if necessary, providing emergency treatment, and using beta-blockers (with caution) for serious tachycardiac arrhythmia.

Connection to the overall overdose profile (2–4 sentences): Regulatory documents define the overdose profile by documenting the severe cardiovascular and metabolic manifestations resulting from excessive exposure. These high-risk findings, such as cardiac arrest and hypokalemia, are the explicit triggers that mandate the immediate discontinuation of the medication and the requirement to consult a physician as soon as possible for the initiation of officially described supportive management measures.

Therapeutic Uses of Caterol

Caterol: Therapeutic Overview

Quick Facts

  • Targeted Use: Short-term management of moderately severe acute pain.
  • Typical Context: Used for pain requiring a high level of relief, frequently after a medical procedure or surgery.
  • Benefit Profile: Provides relief from pain and can support a more comfortable recovery.

Caterol is indicated for the short-term management of adult patients experiencing moderately severe acute pain. This type of pain often requires a level of relief comparable to that of opioid analgesics, and Caterol is frequently used in the postoperative setting to help manage discomfort. The medication is used to address pain that starts suddenly and is expected to last for a limited time.

Its function involves mediating the processes in the body that contribute to pain and inflammation, which may assist in a person's return to typical daily activities by providing pain relief. This medication is not intended for the management of mild or long-term chronic painful conditions.

Eligibility and Restrictions for Use

Caterol (indacaterol) is a long-acting beta-agonist (LABA) primarily indicated as a maintenance bronchodilator treatment for adults with Chronic Obstructive Pulmonary Disease (COPD), which includes chronic bronchitis and emphysema. It is not intended for the treatment of acute, severe COPD attacks.

Contraindications

Caterol is generally contraindicated for use in patients with a history of hypersensitivity or allergy to indacaterol or any of the product's ingredients. It is also contraindicated in asthma patients unless they are simultaneously using a long-term asthma control medication, such as an inhaled corticosteroid.

Special Populations and Considerations

Population Guideline for Use
Pediatric Not indicated; safety and efficacy are not established.
Geriatric No dose adjustment is typically required; generally well-tolerated.
Pregnancy Use only if the potential benefit justifies the potential risk to the fetus; not well-studied in pregnant women.
Lactation Use with caution, as the drug has been detected in the milk of lactating rats.
Severe Hepatic Impairment Data is limited; use with caution.

Caution is advised for patients with certain pre-existing conditions, including severe cardiovascular disorders (e.g., heart rhythm problems, high blood pressure), diabetes mellitus, hyperthyroidism, or a history of seizure disorders.

What should I know about interactions with other medicines?

Official Interaction Restrictions

The interaction profile for Caterol (Procaterol) is defined by specific regulatory restrictions and pharmacological outcomes documented in official government sources.

Contraindicated and Antagonistic Combinations

Co-administration with Catecholamines (such as Adrenaline or Isoprenaline) is highly restricted due to the documented risk of arrhythmias or cardiac arrest. This prohibition reflects the severe augmentation of adrenergic effects. The concurrent use of Beta-blockers is also documented to reduce the therapeutic efficacy of Caterol, an antagonistic effect arising from competing actions at the beta2-adrenoreceptors.

Interactions Affecting Serum Potassium

Certain drug classes are officially noted to increase the risk of a significant decrease in serum potassium levels (hypokalemia) when co-administered with Caterol. These agents include Xanthine Derivatives (e.g., Theophylline), Corticosteroids, and Diuretics. This documented exposure-modifying effect is associated with an increased risk of cardiovascular adverse reactions.

Metabolic and Population Considerations

Regulatory documentation identifies Procaterol as a CYP3A/CYP3A4 substrate, indicating the metabolic pathway involved in clearance. Furthermore, the risk of aggravated hypokalemia with co-administered substances is explicitly noted as requiring extreme care in the sub-population of patients with severe asthma. This constitutes a formal, population-specific interaction constraint defined in official labeling.

Mechanism of Action

Procaterol (Caterol) exerts its function through a highly targeted mechanism focused exclusively on the beta2-Adrenoreceptor to influence muscle tone and cellular signaling within the airways. The compound initiates a rapid sequence of events that translates molecular action into immediate physiological change.

Molecular Targeting and Airway Smooth Muscle Tone

The mechanism begins with Procaterol acting as a selective agonist on the beta2-Adrenoreceptors located on the bronchial muscle cells. This targeted interaction initiates a rapid intracellular signaling cascade, specifically activating the cAMP second messenger system. This cascade is critical because it ultimately promotes the sequestration of intracellular calcium ions ( Ca^2+). The reduction of Ca^2+ levels directly inhibits the muscle's contractile apparatus, resulting in smooth muscle relaxation and an increase in bronchial luminal diameter.

Secondary Mechanism: Influencing Mediator Release

Beyond its direct effect on muscle tone, the beta2-receptor mechanism also influences the function of local immune cells, such as mast cells. The increased cAMP signaling in these cells stabilizes their structure, which suppresses the release of endogenous bronchoconstricting and inflammatory molecules like histamine and leukotrienes. This supplementary action complements the primary action on muscle tone by limiting the impact of internal signaling mediators that would otherwise promote constriction, influencing the level of physiological responsiveness in the airways.

Dosage and Administration Information

Official Administration Guidelines

Caterol, containing procaterol hydrochloride, is administered via two primary, officially approved methods: the oral route (using tablets or syrup) and the inhalation route (using nebulized solutions or dry powder inhalers). The choice of administration method is determined by the patient’s overall treatment plan, and adherence to specific instructions ensures correct use.

The standard adult oral dose is 50 mu g of procaterol hydrochloride per administration. Oral dosing frequency is often set for once daily or twice daily. Consistent timing is emphasized, frequently specifying the administration for the morning and before bedtime for the twice-daily regimen. The inhalation route may allow for administration up to four times daily, provided the total prescribed daily limit is strictly followed.

Precise, age-specific dosing rules are established in the official prescribing information. For children aged six years and older, the oral dose is typically 25 mu g once or twice daily. For children under six years old, the dose is calculated proportionally to body weight, at 1.25 mu g per kilogram of body weight, given two or three times daily.

Procedural constraints require specific handling of the medication. Nebulized solutions must be used immediately after opening the unit-dose container and are for single use only. If a dose is missed, patients are directed to skip the missed dose and resume the schedule at the next designated time, never taking two doses to compensate. Caterol is used as an additional therapy and is not intended to replace existing anti-inflammatory maintenance medications.

Recent Clinical Evidence

Evidence for Monotherapy

Studies explored the drug's potential effects on two specific components of the pain pathway. Clinical trials examined this dual approach in relation to reported symptoms. Phase III clinical trials examined changes in the quality of life in participants with chronic pain, with changes in reported pain being studied compared to a placebo. Initial observations of changes in reported pain occurred within the first week in some participants, and clinical trials examined treatment continuation for periods of up to six months. Research protocols utilized the 200mg twice-daily dose in most studies.

Safety and Tolerability

Early-phase trials focused on determining the maximum tolerated dose. The most frequent adverse events reported included mild dizziness and nausea, which were observed to decrease over the study period. In clinical trials, the drug was studied in adults aged 18 to 65. Studies excluded participants with severe liver impairment. Long-term data examined the continued effect and safety profile over time.

Evidence for Combination Therapy

Research has explored the effects of combining this drug with standard physical therapy. Comparisons examined whether patient outcomes differed when receiving the combination versus either treatment alone. Studies also evaluated the use of rescue pain medication when the combination was utilized. The evidence remains limited regarding the long-term impact of combination therapy.

Frequently Asked Questions (FAQ)

Common questions about Caterol (FAQ)


Q: What are the most common side effects people experience when taking Caterol?

According to official product information, common side effects reported with procaterol include palpitations (a fluttering heart sensation), tachycardia (a fast heart rate), tremor, and headache. Gastrointestinal issues such as nausea and vomiting are also frequently reported.

Q: Can Caterol cause stomach upset, and is it better to take it with food?

Official documentation lists gastrointestinal disturbances, such as nausea and vomiting, as possible adverse reactions. While stomach upset is possible, the official labeling for the tablet form often indicates that it can be taken with or without food.

Q: Does Caterol interact with blood pressure medications?

Yes, regulatory documents state that co-administration with certain agents, such as beta-blockers and catecholamines, is highly restricted or contraindicated. This is because these combinations may increase the risk of adverse cardiovascular events.

Q: Can taking Caterol affect my heart, especially if I have a pre-existing heart condition?

Official documentation indicates that Caterol may cause cardiac effects, such as palpitations and changes to heart rhythm. Caution is advised for patients with pre-existing severe heart disease due to the potential for exacerbation of these conditions.

Q: Is it possible to have an allergic reaction to Caterol, and what are the signs?

Serious anaphylactic reactions, which are severe allergic events, are explicitly listed as rare but possible events in official labeling. A severe hypersensitivity reaction, such as anaphylactic shock, is listed as a possibility, which includes severe symptoms. Any signs of a severe reaction require immediate attention.

Q: What are the risks of taking Caterol if I have a history of stomach ulcers or bleeding?

While gastrointestinal side effects like nausea and vomiting are noted on the procaterol label, specific risks related to stomach ulcers or active bleeding are not formally listed in the primary safety information. A patient's history of serious gastrointestinal issues is a factor that is considered by healthcare professionals when prescribing.

Q: Is Caterol safe for use in older adults (seniors)?

For the COPD treatment (indacaterol), older adults are generally well-tolerated and usually do not require special dosage changes. For the asthma medicine (procaterol), the dosage may be adjusted based on the patient’s age and overall symptoms.

Q: Does Caterol interact with blood thinners or antiplatelet medications?

Official regulatory documents explicitly list restrictions with medicines like beta-blockers, corticosteroids, and diuretics. However, the official documentation does not explicitly list warnings or restrictions regarding common blood thinners (anticoagulants) or antiplatelet medications.

Q: Is it normal to feel dizzy or drowsy after taking Caterol?

Official studies indicate that dizziness is a reported adverse event, particularly in early-phase trials. While dizziness is noted, formal regulatory labels do not commonly list drowsiness as a frequent side effect.

Q: Are there any known interactions between Caterol and alcohol?

Official regulatory documents provide warnings for many drug-drug interactions, but they do not explicitly list known interactions with alcohol consumption.

Q: Can Caterol be used safely while breastfeeding?

Regulatory information indicates that the use of Caterol during breastfeeding should be considered cautiously. Due to detection in animal milk, clinicians may recommend interruption of nursing while using procaterol.

Q: Does Caterol increase the risk of a stroke or heart attack?

Official documentation indicates a risk of cardiovascular effects, including serious arrhythmias (irregular heartbeat). While the documentation notes risks of cardiac effects and arrhythmias, the official regulatory text does not explicitly detail an increased risk of stroke or heart attack.

Q: What should I do if I accidentally take Caterol for more than five days?

Official guidance indicates that if an abnormality occurs, or if the prescribed duration of treatment is exceeded, medical guidance is necessary. Overdosage may be associated with symptoms like tachycardia, arrhythmia, tremor, and low potassium levels (hypokalemia). Consultation with a healthcare professional is recommended in this situation.

Q: Is Caterol suitable for patients who are dehydrated?

The drug's use in dehydrated patients requires clinical care. This is because the medicine carries a known risk of causing a significant drop in serum potassium levels (serious hypokalemia), and dehydration can potentially aggravate this condition.

Q: Can Caterol cause problems with sleep, such as insomnia?

Yes, insomnia (difficulty sleeping) is listed among the common adverse reactions reported in the official regulatory documentation for Caterol.

Q: What is the effective half-life of Caterol, and how does this relate to its dosing schedule?

For the long-acting form (indacaterol), the effective half-life is approximately 40 to 56 hours. Procaterol, the fast-acting agent, has a shorter half-life that aligns with its own specific treatment regimen.

Q: Does Caterol need to be tapered off, or can I stop taking it suddenly after the course is complete?

It is important that the course of treatment is followed as prescribed. Official product information advises against stopping the medicine suddenly unless specifically directed by a healthcare professional.

Q: Is there a generic version of Caterol available?

Caterol is a trade name for the active ingredient procaterol. Procaterol is available under multiple brand names and generic names in different markets globally.

Q: How is the mechanism of action of Caterol different from a steroid pain reliever?

Caterol is a bronchodilator that works by directly relaxing the airway smooth muscles. This action is separate from that of corticosteroids (steroids), which reduce inflammation more broadly. Using both Caterol and a corticosteroid may increase the risk of low potassium levels (hypokalemia).

Q: What are the serious, but less common, side effects of Caterol?

Official regulatory documents highlight serious adverse reactions that are not common but are clinically significant. These include severe hypokalemia (dangerously low potassium levels) and anaphylactic reactions, which can lead to shock.

Q: Can Caterol cause photosensitivity or a skin rash?

Yes, skin rash is listed among the possible adverse reactions to Caterol reported in official product information.

Q: Can Caterol be taken if I have high blood pressure?

Caution is advised for patients who have pre-existing cardiovascular disorders, which include high blood pressure. The drug may cause effects such as tachycardia and arrhythmias. Patients with cardiovascular conditions, including high blood pressure, require careful consideration by a healthcare professional.

Q: Is the maximum daily dose of Caterol different for older patients?

The maximum daily dose for the COPD treatment (indacaterol) is typically not adjusted for older patients. For the asthma treatment (procaterol), the dosage may be adjusted based on the patient's age and clinical symptoms.

Q: Does Caterol interact with antidepressant medications?

Official regulatory documents list specific drug classes that interact with Caterol, such as beta-blockers and xanthine derivatives. However, specific warnings or interactions with common antidepressant medications are not explicitly noted.

Q: Can Caterol cause changes in mood or anxiety?

Nervousness is listed as a common adverse reaction, which may be more noticeable when starting treatment. Official documentation does not explicitly list changes in mood or anxiety as common side effects.

Q: What are the concerns about taking Caterol late in pregnancy?

The safety of procaterol use during pregnancy has not been established through adequate studies. It should only be used when the expected therapeutic benefit for the mother is judged to outweigh any possible risk to the unborn child.

Q: What are the most common GI-related side effects aside from ulcers?

The most commonly reported gastrointestinal adverse reactions listed in the regulatory documents are nausea and vomiting.

Q: What are the signs of liver problems that could be caused by Caterol?

Official reports indicate that elevations in liver enzymes (transaminases) have been noted as an adverse event. If signs of potential liver impairment are noticed, medical guidance is needed.

How should Caterol be stored and disposed of?

Storage Requirements

Official regulatory documentation requires that Caterol (Procaterol hydrochloride hydrate) be stored at controlled room temperature, typically defined as not exceeding 25 C or 30 C. The medicine must be kept in its original container and stored in a dry place, protected from light. This protection is mandatory to maintain the product's chemical stability.

Stability and Handling

Certain liquid forms, such as the syrup, have an in-use shelf-life and must be discarded after a set period (e.g., 30 days) following first opening. Single-unit dose inhalation solutions must be discarded immediately after use. All Caterol formulations must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Caterol must not be thrown away with household waste or disposed of via wastewater. Disposal must be conducted in accordance with local regulations for pharmaceutical waste, often involving returning the medicine to a designated collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Caterol found in:

A-Z Index: